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Participation 18 to 24 months after initial training was 73.5%. In
mixed models adjusted for participant and state characteristics, the
intervention group improved significantly in the overall skill gap
(P = .01) and in 6 skill areas. Among the 4 organizational variables, only access to evidence and skilled staff showed an intervention effect (P = .04).
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Conclusion

Abstract

Tailored and active strategies are needed to build capacity at the
individual and organization levels for evidence-based decision
making. Our study suggests several dissemination interventions
for consideration by leaders seeking to improve public health practice.

Introduction
Although practitioners in state health departments are ideally positioned to implement evidence-based interventions, few studies
have examined how to build their capacity to do so. The objective
of this study was to explore how to increase the use of evidencebased decision-making processes at both the individual and organization levels.

Methods
We conducted a 2-arm, group-randomized trial with baseline data
collection and follow-up at 18 to 24 months. Twelve state health
departments were paired and randomly assigned to intervention or
control condition. In the 6 intervention states, a multiday training
on evidence-based decision making was conducted from March
2014 through March 2015 along with a set of supplemental capacity-building activities. Individual-level outcomes were evidencebased decision making skills of public health practitioners; organization-level outcomes were access to research evidence and participatory decision making. Mixed analysis of covariance models
was used to evaluate the intervention effect by accounting for the
cluster randomized trial design. Analysis was performed from
March through May 2017.

Introduction
An evidence-based approach to chronic disease prevention and
control can significantly reduce the burden of chronic diseases (1).
Large-scale efforts such as Cancer Control P.L.A.N.E.T. (https://
cancercontrolplanet.cancer.gov/) and the Community Guide
placed various evidence-based interventions in the hands of cancer control practitioners (2). Even with knowledge of effective interventions, often 15 to 20 years elapse before research findings
are incorporated into practice (3). Knowledge of effective approaches for dissemination of evidence-based interventions is
growing (4,5). Practitioners in state health departments can assess
a public health problem, develop an appropriate program or policy
to address the problem, and ensure that programs and policies are
effectively delivered and implemented (6).
The process of evidence-based decision making (EBDM) involves multiple elements, including making decisions that are
based on the best available scientific or rigorous evaluation evidence, applying program planning and quality improvement frame-
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works, engaging the community in assessment and decision making, adapting and implementing evidence-based interventions for
specific populations or settings, and conducting sound evaluation
(7). To select and implement evidence-based interventions in diverse populations and settings, advanced knowledge and skill is
needed in key processes (eg, adaptation of interventions, evaluation) (8).
Previous research with state health agencies showed that although
levels of awareness of EBDM is high, implementation of evidence-based interventions varies widely and is limited in many
states (9). Similarly, another study found that although cancer control practitioners showed a strong preference for programs with
proven effectiveness, fewer than half of respondents in that study
(48%) had ever used resources on evidence-based interventions
(10). A national survey of state practitioners in chronic disease
control found that only 20% used evidence-based interventions often in their work (11). Nonetheless, staff members in state public
health agencies recognize the need for capacity building to support implementation of effective practices (10).
Putting evidence to use in public health settings requires sufficient capacity — the availability of resources, structures, and
workforce to deliver the preventive dose of an evidence-based intervention (12). Capacity is a determinant of performance; that is,
greater capacity is linked with greater effect on public health
(13,14). Success in implementing EBDM in public health settings
is achieved by building the skills of individuals (eg, their ability to
carry out a program evaluation) and organizations (eg, achieving a
climate and culture that supports innovation and evidence-based
approaches) (12). These 2 skills are interrelated in that individuals
shape organizations and organizations support the development of
individuals (15).

tensive EBDM training, and 3 states that had no logical pair
match. State exclusion criteria are detailed elsewhere (16). The remaining 33 states were organized into tertiles according to state
population size. Two pairs from each state population tertile were
selected in 3 rounds of staggered selection and enrollment. Each
round consisted of 1 state randomly selected from each of 2 tertiles and matched with the nearest population-sized state within
the tertile. Six state health department’s chronic disease prevention units (hereinafter called states) were selected via a simple randomization method by our data analyst (R.R.J.) and then pairmatched with the state closest in population size, to decrease
between-state variability, for a total of 6 pairs (6 intervention
states and 6 control states, 1 each per pair). We then invited the
states to participate by contacting the chronic disease director in
each state health department. Two states declined to participate,
and we selected the state with the nearest population in the tertile
to replace that state to retain our total of 12. After pairing and obtaining consent from the lead chronic disease official, whom we
designated as the state-level representative, the 2 states in each
pair were randomly assigned to the intervention arm or control
arm. There was no blinding. Enrollment of state pairs, data collection, and intervention trainings were staggered for scheduling feasibility. Enrollment of states took place from September 2013
through May 2014. The trial was registered with
ClinicalTrials.gov (NCT01978054) (17). The study was approved
by the Washington University in St. Louis Institutional Review
Board (no. 201111105).

To date, little research has addressed the most effective approaches for building capacity for EBDM in state public health
agencies seeking to address chronic disease prevention and control. The objective of this study was to test whether providing
training and other support to state health departments increased the
use of EBDM processes to prevent chronic diseases at both the individual level (eg, reducing skill gaps) and the organization level
(eg, increasing participatory decision making).

Methods
We conducted a 2-arm, group-randomized trial consisting of an intervention arm and a control arm (Figure). We assessed 50 states
and the District of Columbia for eligibility. We excluded 3 states
with the lowest burden of cancer and overall chronic disease, 3
states with the lowest capacity for EBDM, 2 states with the
highest capacity for EBDM, 7 states that had already received exThe opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services,
the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions.
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strategies intended to build an organizational culture of EBDM,
improve staff access to research evidence, share information, and
build evaluation capacity (Appendix Table 1). Follow-up conference calls with intervention states provided technical assistance
and supplemental activity planning and updates.
Control states. Control states identified participants for data collection and received a list of EBDM resources, web links, and
state-specific baseline and post-intervention findings. They received no training, and all control state participants were asked to
complete an online baseline survey before their paired state’s multiday training.

Participants
Study participants were 2 groups of chronic disease control practitioners at the state and local level, an intervention group and a
control group. These were people who directed and implemented
population-based intervention programs in government agencies
or in community-based coalitions. Participants were directly involved in delivering programs, setting priorities, or allocating resources for programs related to chronic disease risk factors or
screening. Examples were the director of a comprehensive chronic disease program for the state or a leader in a state or regional
chronic disease control coalition.

Figure. Flow diagram of the study of evidence-based decision making
conducted in 12 states, 2014–2016 (CONSORT diagram).

Intervention
Intervention states. The intervention began with a 3.5-day training
in EBDM conducted onsite at each of the 6 intervention states
between March 2014 and March 2015. Training details are described elsewhere (18). The lead official responsible for chronic
disease control in each state assisted the team in recruiting training participants from among their staffs and sometimes included
staff members from state or local partnering organizations. A total
of 222 staff members attended a multiday EBDM course in 1 of
the 6 intervention states. All intervention state participants were
asked to complete an online baseline survey before the multiday
training. Each intervention state received a report on its baseline
survey results for planning purposes and selected supplemental capacity-building activities, typically brief trainings or management

The intervention arm comprised 2 groups: a primary group and a
secondary group. The primary group in each intervention state was
made up of staff members who attended the EBDM course; most
worked in state health departments and a few were from state or
local partnering organizations. The secondary group in each intervention state, none of whom attended the EBDM course, was
made up of chronic disease staff members and partnering staff
members from each state health department, local health departments, universities, and coalitions (collaborators). Collaborators
were surveyed because they were expected to apply EBDM in
their organizations for control of chronic diseases as funded or
guided by the state. Inclusion of collaborators also helped the
study team meet sample size requirements. All participants were
aged 20 years or older and able to take an online survey in English. Across the entire sample, most participants worked either in
chronic disease risk reduction or chronic disease screening.

Measures, data collection, and statistical analysis
Measures in the 65-item online Qualtrics Version January
2014–November 2016 (Qualtrics) survey were informed by a literature review (13) and earlier research by the study team (16,19).
Measures, described in detail elsewhere (16,20,21), were tested
with cognitive response methods and test–retest reliability (16).
Survey questions assessed individual-level skills (eg, adapting interventions, action planning, communicating to policy audiences)
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and organizational-level capacities (eg, access to evidence, program evaluation, perceived supervisory expectations) (Appendix
Table 2). Survey participants were asked to rate on a 11-point
Likert scale the perceived importance and perceived availability of
10 EBDM skills.
Online self-report surveys were administered, by state, at 2 points
at staggered times: 1) a baseline survey conducted from January
2014 through December 2014 and 2) a post-intervention survey
conducted from October 2015 through November 2016, 18 to 24
months after the state pair’s EBDM training. The study team followed up each returned post-survey email invitation to determine
whether the participant had left the agency or just had a new email
address and recorded reasons for declining among those who declined the post-survey by telephone or email.
The unit of analysis was individual staff members, with individuals from all 12 clusters (states) who completed both surveys included in analyses. We calculated baseline intra-cluster correlations for the dependent variables using standard methods to assess
need for mixed modeling, but we elected to conduct mixed modeling as a conservative approach regardless of result. One-stage
mixed analysis of covariance (ANCOVA) models were fitted by
using PROC MIXED (SAS Inc) with state as a random effect to
account for clustering by state (22). The between–within method
was used to calculate denominator degrees of freedom for the
fixed effect instead of the SAS default containment method, because it is more appropriate for unbalanced study designs. SAS
version 9.4 was used for descriptive analyses and mixed ANCOVA modeling, and SPSS version 24 (IBM Corp) was used to
clean and recode data and create calculated variables. Covariates
were included in final ANCOVA models when the unadjusted effect size was attenuated by 10% or more on the basis of addition
of a particular covariate to the model (23). Sex was included in all
adjusted models as required in studies funded by the National Institutes of Health. All tests of significance were 2-sided, including
the χ 2 tests and independent samples t tests used to compare
baseline participant characteristics and scores. The sample size
calculation of the study is described elsewhere (16).
The primary individual-level outcomes were gaps in EBDM skills
among public health practitioners and their use of research evidence for job tasks. The primary organization-level outcomes were
access to research evidence and the presence of a staff with
EBDM skills, supervisory expectations for EBDM use, evaluation,
and work unit participatory decision making as assessed through
individuals’ perceptions. The main analyses compared data on the
primary intervention arm participants with data on control participants; we also compared data on secondary intervention arm participants and control participants.

We calculated gaps in the 10 EBDM skill scores by subtracting the
score in perceived availability from the score in perceived importance for each individual for each skill. Higher gap scores indicate
larger gaps. A summary score for gaps in skills was calculated for
each individual by summing the values for gaps in scores for the
10 EBDM skills. A summary frequency of use of research evidence for job tasks was the calculated mean of the 6 job task responses.
We used items from a 7-point Likert scale (1 = “strongly disagree”
and 7 = “strongly agree”) to conduct exploratory factor analysis
with orthogonal rotation to create individual scores for 5 factors:
1) access to research evidence and resources (4 items), 2) evaluation capacity (3 items); 3) supervisory expectations (3 items), 4)
participatory decision making (3 items), and 5) agency leadership
support (3 items) as in a previous national survey with state health
department public health practitioners (21). By definition, the
factor scores had a mean of zero and were normally distributed.
One or more organization behavior items were left blank by 34 of
the 567 survey participants (6.0%); these participants were excluded from factor score creation and mixed ANCOVA modeling.

Results
At baseline, 1,237 of the 1,508 invited public health practitioners
completed the online survey (82.0% response, 83.6% for the 6 intervention states, 80.2% for controls). At follow-up, 909 (73.5%)
of baseline participants completed the post-intervention survey,
with a median of 73 participants per state (mean, 75.8; standard
deviation [SD], 10.6). Loss to survey follow-up was primarily due
to staff turnover. Of the 222 people assigned to the primary intervention arm who attended the EBDM training, 148 (66.7%) completed both baseline and post-intervention surveys (Table 1); of
the 439 secondary intervention arm participants, 342 (77.9%)
completed both surveys, and of the 580 control participants, 419
(72.2%) completed both surveys. Overall, most baseline survey
participants were women (80.6%), and 64.3% had at least a master’s degree in any field. At baseline, primary intervention participants differed significantly from control participants in several
characteristics: for example, the percentage working in state health
departments, age, and the percentage holding a master’s degree or
doctorate in public health. The number of primary intervention
arm participants varied by state from 18 to 32, and the number of
control participants varied by state from 65 to 72.
The largest EBDM skill gaps at baseline were for adapting interventions, economic evaluation, and communicating research to
policy makers (Table 2). Mean scores at baseline did not differ
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significantly between groups, except for 3 skills: adapting interventions (t = 2.49, P = .01), economic evaluation (t = 2.10, P =
.04), and community assessment (t = 2.01, P = .04). Baseline intracluster correlations were low in all the states (ranging from <.001
to .018), indicating low correlation of responses within states.
The primary intervention group significantly improved in the
overall skill gap (P = .01) and in 6 skill areas compared with the
control group (Table 3). In the comparison of secondary intervention arm participants and control participants, intervention effects
on the 10 skill gaps were attenuated and no longer significant.
Sex was included in all adjusted mixed ANCOVA models and did
not affect sizes of intervention effects. Sex was not associated with
gaps in skills, except that men were more likely than women to
have a smaller gap in qualitative evaluation when we adjusted for
other characteristics (β = −0.55, t = −2.45, P = .03). Having at
least a master’s degree in any field was associated with increased
use of research evidence for job tasks (β = 0.18, t = 2.93, P = .01)
and with increased supervisory expectations of EBDM use (β =
0.24, t = 2.46, P = .03). Being in a leadership position was associated with increased participatory decision making, compared with
the reference group of program managers (β = 0.27, t = 2.22, P =
.03). Other participant and state characteristics did not affect the
models. Among the 4 organizational capacity dependent variables,
only access to evidence and skilled staff showed an intervention
effect (t = 2.73, P = .04). In the comparison of secondary intervention arm participants and control participants, no intervention effects were significant for organization-level outcomes.

Discussion
Our study is among the first to test the effects of strategies to increase the use of EBDM processes among public health practitioners engaged in controlling chronic diseases. We sought to reduce
the gap between the generation of evidence and its application in
practice settings, which can be viewed as “leakage in the dissemination pipeline” from discovery to application (24). In large part,
this leakage relates to lack of individual and organizational capacity to practice EBDM (12).
Our 12-state study showed improvements in individual-level capacity in several skill areas, although for the content area with the
largest baseline gap (economic evaluation), we saw no improvement. Although deficits in EBDM competencies among state-level
practitioners appear to be narrowing over time (25), interventions
like ours probably can narrow the gap more rapidly. The skill
areas of interest were derived from a systematic process (26) and
are essential for making use of many online tools and toolkits for
chronic disease control (eg, the Community Guide, Cancer Control P.L.A.N.E.T.).

In a systematic review of dissemination studies of cancer prevention in community settings (5), the role of organizational factors in
the uptake of evidence-based interventions was scarcely examined.
We sought to increase the variety of organization-level variables.
Our interventions did not result in significant improvements in
measures of organizational capacity. The exception was for the 4item factor on access to evidence and skilled staff. Organizational
change is difficult and requires long-term commitment. It is possible that the interventions in our study were not intensive enough
to result in measureable organizational change in some variables.
Several studies have shown a high rate of turnover in state public
health agencies (27). This ever-changing workforce may make it
difficult to develop and maintain an organizational climate and
culture supportive of EBDM.
Limitations of this study should be noted. It was difficult to gather
objective data on practitioner or agency performance. Although
data were well-tested psychometrically, we relied on self-reported
(perceived) data on individual-level and organization-level outcomes. We assessed no direct chronic disease outcomes (eg, does
greater use of research by practitioners lead to better chronic disease outcomes?), yet a substantial body of literature shows that the
variables we measured on EBDM lead to better performance (13).
Performance over time was probably improving in our control
group given that many programs funded by the Centers for Disease Control and Prevention now require grantees to implement
EBDM. Although it is established that individuals influence organizations and the reverse (12), our finding that only 1 of 4 organization-level outcomes was affected by our intervention suggests that more intensive interventions and longer time periods
may be needed to change an organization’s climate and culture.
Given that our intervention group included only 6 states, our findings may not be generalizable to all states.
This study should be considered first-generation research and can
be viewed in the context of the growing literature on dissemination and implementation research (12). Several topics deserve future consideration among practitioners and researchers. First, more
tailored, active approaches are warranted. It is unclear whether our
study approach was intensive enough to sustain positive changes.
In addition, larger effects for subgroups (eg, master’s
degree–trained individuals) suggest approaches may need to be
adapted for various staff categories. The skill sets for health department staff members may differ from those needed among partners outside of a public health agency. Second, there is a need for
better measures of EBDM. One of the greatest needs among
chronic disease control practitioners is how to better assess organizational capacity (28). Most existing measures focus on ultimate
outcomes, such as change in health status. Most existing measures
of capacity have not been tested adequately for reliability and pre-
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dictive validity (29). Third, capacity building needs to occur in the
context of staff turnover. The rate of turnover among participants
in our study was substantial, suggesting that frequent exposure to
EBDM processes may be needed as new staff members are hired
and trained. Fourth, the lack of change in some skill areas (eg,
economic evaluation) may call for more intensive skill building or
seeking out partners (eg, university staff) to help with more complex content areas. Fifth, more attention is needed on driving organizational change. Changing organizational culture and climate
to an environment supportive of EBDM takes time and concerted
effort (30). The intervention activities in our study may not have
been intensive enough to foster measureable change in organizations, especially considering the heterogeneity in organizations.
To control chronic disease at a population level, EBDM requires a
complex set of individual skills and organizational capacity. Our
findings suggest several dissemination interventions that should be
considered by practitioners as they seek to apply EBDM in their
agencies to ultimately benefit the populations they serve.
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Tables
Table 1. Characteristics of Participants at Baseline Among Primary Intervention Participants and Controls in 12 States, Study of Evidence-Based Decision Making,
2014–2015a
Characteristic

Primary bIntervention
Group (n = 148)

Overall (n = 567)

State health department

Control Groupc (n = 419)

56.6

81.8

47.7

Leadership position

17.0

16.9

17.0

Program manager or coordinator

48.2

50.0

47.6

Health specialist

30.6

30.4

30.6

P Valued
<.001

Position type

Other type specified

.74

4.2

2.7

4.8

80.6

84.4

79.3

20–29

5.4

10.3

3.6

30–39

20.4

23.3

19.4

40–49

26.1

24.0

26.9

50–59

33.1

30.1

34.1

≥60

15.0

12.3

16.0

Master’s degree or higher in any field

64.3

64.9

64.1

.86

Public health master’s degree or doctorate

22.5

35.8

17.7

<.001

Nursing degree

10.5

11.9

10.2

.66

14.5 (7.6)

16.8 (9.4)

13.7 (6.7)

<.001

Small

32.1

34.5

31.3

Mid-size

34.9

37.8

33.9

Female

.18

Age, y

.02

Education

Chronic disease prevention and control revenue from CDC
as of October 2014, in millions of dollars, mean (SD)
Size of state population, by tertile

Large

.28

33.0

27.7

34.8

Percentage of state population living in urban area, mean
(SD)

68.9 (15.2)

67.4 (10.1)

69.4 (16.6)

.09

Percentage of state population living in poverty, mean (SD)

14.6 (4.2)

12.4 (3.8)

15.4 (4.0)

<.001

All Republican control

51.8

51.4

52.0

Divided party control

27.3

12.8

32.5

All Democratic control

20.8

35.8

15.5

State political party control in 2014 of governorship, state house, state senate

<.001

Abbreviation: CDC, Centers for Disease Control and Prevention; SD, standard deviation.
a
Values are percentages unless otherwise indicated. Only participants who completed the baseline survey and follow-up survey (18 to 24 months later) were included in the analysis.
b
Intervention arm comprised a primary group, which attended an evidenced-based decision-making course, and a secondary group, which did not attend an
evidenced-based decision-making course but participated in other training activities.
c
Control group received no training.
d
P values calculated by using 2-sided χ2 or t test to test differences between primary intervention group and control group.
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Table 2. Mean Scores at Baseline and Post-Intervention in 12 States, Study of Evidence-Based Decision Making, 2014–2016
Primary Intervention Groupa, Mean (95% CI)
(n = 148)
Dependent Variable

Baseline

Post-Intervention

Control Groupb, Mean (95% CI) (n = 419)
Baseline

Post-Intervention

P Valuec

Individual Capacity
EBDM skill gapd (10-item sum)

20.4 (17.8 to 23.1)

15.3 (12.8 to 17.9)

18.3 (16.6 to
19.9)

17.6 (16.0 to 19.1)

.17

Prioritization

1.7 (1.4 to 2.0)

1.0 (0.7 to 1.3)

1.7 (1.5 to 1.8)

1.4 (1.2 to 1.6)

.79

Adapting interventions

2.6 (2.2 to 2.9)

1.8 (1.5 to 2.2)

2.0 (1.8 to 2.2)

2.1 (1.8 to 2.3)

.01

Quantifying the issue

1.5 (1.1 to 1.9)

0.9 (0.6 to 1.3)

1.4 (1.2 to 1.6)

1.4 (1.2 to 1.6)

.71

Evaluation designs

2.1 (1.7 to 2.6)

1.6 (1.2 to 2.0)

1.9 (1.7 to 2.1)

1.9 (1.7 to 2.1)

.34

Quantitative evaluation

1.3 (0.9 to 1.6)

1.0 (0.7 to 1.3)

1.3 (1.1 to 1.5)

1.3 (1.1 to 1.5)

.99

Qualitative evaluation

1.9 (1.5 to 2.3)

1.4 (1.0 to 1.8)

1.7 (1.5 to 1.9)

1.7 (1.5 to 2.0)

.32

Economic evaluation

3.5 (3.0 to 4.0)

3.5 (3.0 to 4.0)

2.9 (2.6 to 3.2)

2.8 (2.528 to 3.1)

.04

Action planning

1.3 (1.0 to 1.6)

0.9 (0.6 to 1.2)

1.2 (1.1 to 1.4)

1.0 (0.8 to 1.2)

.88

Community assessment

1.9 (1.6 to 2.2)

1.3 (1.0 to 1.7)

1.5 (1.3 to 1.7)

1.5 (1.3 to 1.7)

.04

Communicating research to policy
makers

2.5 (2.1 to 3.0)

1.9 (1.5 to 2.3)

2.6 (2.3 to 2.9)

2.5 (2.2 to 2.8)

.73

Use of research
evidence for job tasks
(6-item mean)e

1.8 (1.7 to 2.0)

2.0(1.9 to 2.1)

1.9 (1.8 to 2.0)

1.9 (1.9 to 2.0)

.52

Organizational Capacityf
Access to evidence and skilled staff
(4-item factor)

−0.1 (−0.2 to 0.1)

0.2 (0.0 to 0.3)

0.1 (−0.0 to 0.2)

−0.1 (−0.2 to 0.0)

.08

Program evaluation (3-item factor)

−0.0 (−0.2 to 0.1)

0.0 (−0.1 to 0.2)

0.1 (−0.0 to 0.2)

0.1 (−0.0 to 0.1)

.30

Supervisory expectations and
incentives factor (3-item factor)

0.1 (−0.0 to 0.3)

0.2 (0.1 to 0.3)

0.0 (−0.1 to 0.1)

0.1 (−0.0 to 0.2)

.34

Participatory decision making factor
(3-item factor)

0.1 (−0.1 to 0.2)

−0.1 (−0.2 to 0.1) −0.0 (−0.1 to 0.1)

0.0 (−0.1 to 0.1)

.28

a

Intervention arm comprised a primary group, which attended an evidenced-based decision-making course, and a secondary group, which did not attend an
evidenced-based decision-making course but participated in other training activities.
b
Control group received no training.
c
P values at baseline calculated by using independent samples t test (2 sided). Test compares gaps at baseline between primary intervention group and control
group.
d
Survey participants were asked to rate on a 11-point Likert scale the perceived importance and perceived availability of 10 EBDM skills; higher scores indicate larger gaps. We calculated gaps in the 10 EBDM skill scores by subtracting the score in perceived availability from the score in perceived importance for each individual for each skill. Observed skill gap scores ranged from −9 to +10 for specific skills and from −66 to +88 for the 10-item summed skill gap.
e
Frequency of research evidence use scores ranged from 0 to 3 for each of 6 job tasks: 3 = weekly, 2 = monthly, 1 = quarterly, and 0 = seldom or never. A mean
score for the 6 job tasks was calculated for each individual and could range from 0 to 3. The group mean frequencies shown in the table are lower than 2 =
monthly.
f
Organizational capacity variables shown here are the group means of the individual factor scores derived from exploratory factor analysis. For the sample overall,
each factor by definition has a mean score of 0 and can range from -3 to +3. Observed group means are close to zero, either slightly below or above the overall
sample mean of zero.
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Table 3. Intervention Effects at the Individual and Organization Levels Adjusteda for Participant and State Characteristics in 12 States, Study of Evidence-Based Decision Making (EBDM),2014–2016
Intervention Effect Parameter Estimateb
Dependent Variable

β (SE)

95% Confidence
Interval

P Valueb

t

Individual
EBDM skill gaps (10-item sum)

−5.56 (1.59)

−9.32 to −1.80

−3.50

.01

Prioritization

−0.58 (0.20)

−1.07 to −0.09

−2.89

.03

Adapting interventions

−0.69 (0.22)

−1.21 to −0.17

−3.13

.02

Quantifying the issue

−0.59 (0.22)

−1.09 to −0.08

−2.69

.03

Evaluation designs

−0.43 (0.24)

−1.00 to 0.14

−1.79

.11

Quantitative evaluation

−0.23 (0.21)

−0.77 to 0.26

−1.21

.33

Qualitative evaluation

−0.59 (0.24)

−1.19 to 0.02

−2.48

.05

Economic evaluation

0.18 (0.28)

−0.51 to 0.87

0.65

.54

Action planning

−0.35 (0.24)

0.91 to 0.20

−1.50

.18

Community assessment

−0.59 (0.22)

−1.11 to −0.06

−2.65

.03

Communicating research to policy makers

−0.96 (0.28)

−1.63 to −0.29

−3.41

.01

0.12 (0.07)

−0.04 to 0.28

1.74

.12

Use of research evidence for job tasks (6-item mean)
Organization
Access to evidence and skilled staff (4- item factor)

0.37 (0.14)

0.02 to 0.72

2.73

.04

Program evaluation factor (3-item factor)

0.03 (0.10)

−0.21 to 0.26

0.28

.78

Supervisory expectations for EBDM (3-item factor)

−0.06 (0.26)

−0.73 to 0.62

−0.21

.84

Participatory decision making (3-item factor)

−0.06 (0.12)

−0.36 to 0.23

−0.57

.59

Abbreviation: SE, standard error.
a
Participant characteristics were sex, agency, job position, age group, having a public health master’s or doctoral degree, and having a master’s or doctoral degree
in any field; state characteristics were accreditation status, chronic disease revenue from the Centers for Disease Control and Prevention to the state public health
department, tertile of state population size, percentage of state population living in urban area, percentage of state population living in poverty, and state party control of the governorship, state senate, and state house.
b
Mixed analysis of covariance (ANCOVA) models with state as a random effect; parameter estimate P values are fixed solution 2-sided t tests within mixed ANCOVA.
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Appendix.
Appendix. Table 1. State Health Department Capacity-Building Activitiesa for Evidence-Based Decision Making (EBDM) in 6 US States, 2014–2016
Domain

Activity

Description

Accreditation

Accreditation preparations

State health assessment and plan, formalized decision making, documentation of
evidence, documentation reviews, site visit, approval

Workforce development

EBDM training

In-state, in-person multiday training in EBDM skills, 9 modules, as initial study intervention

Supplemental brief EBDM skill trainings Provided by study team or state chronic disease unit, in-person or webinar, as part of this
study, with 3 states emphasizing evaluation skills

Leadership, management
supports

Organizational climate

Relationships and
partnerships

Financial practices

Non-study national trainings

Hosted in-person EBDM-related skill trainings by national organizations and/or encouraged
out-of-state training beyond those required by funders

Quality improvement

Quality improvement or performance management trainings, guidance

New employee EBDM orientation

Via archived webinars or course materials, facilitated discussions, meetings

Chronic disease leadership teams
expect EBDM

Leaders and supervisors continually ask “what is the evidence?,” communicate EBDM
expectations to staff, champion EBDM, encourage use of data for decision making,
encourage skill building

Use of data for decision making

Use data to prioritize programs, develop work plans, and monitor progress; share
performance measures, data on intranet or centralized data systems

Centralized data systems

Dashboard development to prioritize, measure, and track objectives and link to evidence
base; share performance measures and data

Meetings incorporate EBDM

Work unit and cross-section meetings address EBDM, present evidence, plans (in
leadership and in training)

Performance reviews and EBDM

Work unit employee evaluations include objectives on EBDM learning and application

Hiring practices address EBDM

Job descriptions, interview questions address EBDM; hire people with public health
competencies; hire specialty staff including evaluators and epidemiologists

Participatory decision making

Staff and partner input obtained, sharing of information for decision making

Common language for EBDM

Creating and using common EBDM language across program areas

Administrative reorganization for
coordination

Organizational restructuring at the unit or section levels to increase coordination across
programs and conduct joint projects across programs

EBDM engrained

EBDM an embedded inseparable aspect of day-to-day work; strong expectation from
leadership; high priority

Learning orientation

Culture supports professional development and ongoing learning, providing links to
webinars, bringing in guest speakers

Partnerships with in-state universities

Ongoing partnering for evaluation, trainings, internship placement

Partner technical assistance and
training

Telephone and in-person guidance for partners’ evidence-based work plans, evaluation,
logic models; provide EBDM trainings to partners

Relationship building

Active steps to build or maintain positive partner relationships with open communication,
trust, mutual respect, ensuring partner engagement and coalition development

Performance-based contracting

Funded partners required to implement evidence-based approaches as prescribed or
selected from a menu, with performance objectives, work plans, and evaluation; holding
contracted partners accountable for evidence-based interventions

Proposals approved internally for EBDM State health department pre-approval process for grant applications to funders with
before submission to funder
requirements to show objectives, evidence basis, performance measures, evaluation plan
a

Not all states participated in all activities.
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Appendix. Table 2. Outcome Measures to Assess Evidence-Based Decision Making Capacity and Supports in 12 States, 2014–2016
Outcomes (Dependent
Variables)

Variable Calculation

No. of
Items

Item Type

Item (or Sample Item)

Individual-level capacity
EBDM skill gaps summary

Sum of 10 calculated gaps

10 Likert 11-point
scale

Score for perceived importance of each skill minus score for
perceived work unit availability of each skill

Skill gap
Prioritization

Perceived importance minus
availability

1 Likert 11-point
scale

Prioritization: Understand how to prioritize program and policy
options

Adapting interventions

Adapting interventions: Understand how to modify programs and
policies for different communities and settings

Quantifying the issue

Quantifying the issue: Understand the uses of descriptive
epidemiology (eg, concepts of person, place, time) in quantifying a
public health issue

Evaluation designs

Evaluation designs: Understand the different designs that are
useful in program or policy evaluation

Quantitative evaluation

Quantitative evaluation: Understand the uses of quantitative
evaluation approaches

Qualitative evaluation

Qualitative evaluation: Understand the value of qualitative
evaluation approaches (eg, focus groups, key informant
interviews)

Economic evaluation

Economic evaluation: Understand how to use economic data in
the decision making process

Action planning

Action planning: Understand the importance of developing an
action plan for how to achieve goals and objectives

Community assessment

Community assessment: Understand how to define the health
issue according to the needs and assets of the
population/community of interest

Communicating research to
policy

Communicating research to policy makers: Understand the
importance of effectively communicating with policy makers about
public health issues

Use of research evidence

Mean of responses

6 Frequency 4
categories

Access to evidence and
skilled staff

Factor created in exploratory
factor analysis (EFA)

4 Likert 7-point scale Agreement with statements:
• My work unit has access to current research evidence for
EBDM
• Informational resources are available to my work unit to
promote the use of EBDM
• My work unit currently has the resources (eg, staff, facilities,
partners) to support application of EBDM
• The staff in my work unit has the necessary skills to carry out
EBDM

Program evaluation

Factor created in EFA

3 Likert 7-point scale Agreement with statements:

How often do you use research evidence to:
• Write a grant application
• Plan or conduct a needs assessment
• Select policies, programs, or other interventions
• Justify selection of interventions to funders, agency leadership,
or external partners
• Evaluate interventions
• Develop materials for local public health, partners

Organization-level capacity

(continued on next page)
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(continued)
Appendix. Table 2. Outcome Measures to Assess Evidence-Based Decision Making Capacity and Supports in 12 States, 2014–2016
Outcomes (Dependent
Variables)

Variable Calculation

No. of
Items

Item Type

Item (or Sample Item)
• My work unit plans for evaluation of interventions before
implementation
• My work unit uses evaluation data to monitor and improve
interventions
• My work unit distributes intervention evaluation findings to
other organizations

Supervisory expectations

Factor created in EFA

Participatory decision making Factor created in EFA

3 Likert 7-point scale Agreement with statements:
• My direct supervisor expects me to use EBDM
• My direct supervisor recognizes the value of management
practices that facilitate EBDM
• My performance is partially evaluated on how well I use EBDM
in my work
3 Likert 7-point scale Agreement with statements:
• When decisions are made within my work unit, program staff
members are asked for input
• Information is widely shared in my work unit so that everyone
who makes decisions has access to all available knowledge
• My work unit engages a diverse external network of partners
that share resources for EBDM
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